WallStreetZenWallStreetZen

NASDAQ: AIDX
20/20 Biolabs Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for AIDX

Based on 1 analyst offering 12 month price targets for 20/20 Biolabs Inc

Min Forecast
$5.00+802.53%
Avg Forecast
$5.00+802.53%
Max Forecast
$5.00+802.53%

Should I buy or sell AIDX stock?

Based on 1 analyst offering ratings for 20/20 Biolabs Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their AIDX stock forecasts and price targets.

AIDX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-05-11

1 of 1

Forecast return on equity

Is AIDX forecast to generate an efficient return?

Company
-345.59%
Industry
21.05%
Market
143.92%
AIDX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AIDX forecast to generate an efficient return on assets?

Company
-91.47%
Industry
11.9%
AIDX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AIDX earnings per share forecast

What is AIDX's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$0.43
Avg 2 year Forecast
-$0.39
Avg 3 year Forecast
-$0.44

AIDX revenue forecast

What is AIDX's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$3.0M
Avg 2 year Forecast
$5.9M
Avg 3 year Forecast
$9.1M

AIDX vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
AIDX$0.55$5.00+802.53%Strong Buy
NVNO$10.29N/AN/A
NXL$0.33N/AN/A
PMI$3.21N/AN/AHold
CODX$1.21N/AN/A
View Top Medical Device Stocks

20/20 Biolabs Stock Forecast FAQ

Is 20/20 Biolabs Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: AIDX) stock is to Strong Buy AIDX stock.

Out of 1 analyst, 1 (100%) are recommending AIDX as a Strong Buy, 0 (0%) are recommending AIDX as a Buy, 0 (0%) are recommending AIDX as a Hold, 0 (0%) are recommending AIDX as a Sell, and 0 (0%) are recommending AIDX as a Strong Sell.

If you're new to stock investing, here's how to buy 20/20 Biolabs stock.

What is AIDX's earnings growth forecast for 2026-2028?

(NASDAQ: AIDX) 20/20 Biolabs's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 29.91%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 60.15%.

20/20 Biolabs's earnings in 2026 is N/A.On average, 3 Wall Street analysts forecast AIDX's earnings for 2026 to be -$5,470,798, with the lowest AIDX earnings forecast at -$5,256,257, and the highest AIDX earnings forecast at -$5,631,704. On average, 3 Wall Street analysts forecast AIDX's earnings for 2027 to be -$4,949,769, with the lowest AIDX earnings forecast at -$4,755,661, and the highest AIDX earnings forecast at -$5,095,351.

In 2028, AIDX is forecast to generate -$5,601,055 in earnings, with the lowest earnings forecast at -$5,381,406 and the highest earnings forecast at -$5,765,792.

What is AIDX's revenue growth forecast for 2026-2028?

(NASDAQ: AIDX) 20/20 Biolabs's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.07%.

20/20 Biolabs's revenue in 2026 is N/A.On average, 3 Wall Street analysts forecast AIDX's revenue for 2026 to be $38,413,071, with the lowest AIDX revenue forecast at $36,906,176, and the highest AIDX revenue forecast at $39,536,858. On average, 3 Wall Street analysts forecast AIDX's revenue for 2027 to be $75,178,774, with the lowest AIDX revenue forecast at $72,241,604, and the highest AIDX revenue forecast at $77,400,806.

In 2028, AIDX is forecast to generate $115,788,337 in revenue, with the lowest revenue forecast at $111,242,109 and the highest revenue forecast at $119,185,238.

What is AIDX's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: AIDX) forecast ROA is -91.47%, which is lower than the forecast US Medical Devices industry average of 11.9%.

What is AIDX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year AIDX price target, the average AIDX price target is $5.00, with the highest AIDX stock price forecast at $5.00 and the lowest AIDX stock price forecast at $5.00.

The Wall Street analyst predicted that 20/20 Biolabs's share price could reach $5.00 by May 11, 2027. The average 20/20 Biolabs stock price prediction forecasts a potential upside of 802.53% from the current AIDX share price of $0.55.

What is AIDX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: AIDX) 20/20 Biolabs's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that AIDX's EPS will be -$0.43 for 2026, with the lowest EPS forecast at -$0.41, and the highest EPS forecast at -$0.44. On average, analysts forecast that AIDX's EPS will be -$0.39 for 2027, with the lowest EPS forecast at -$0.37, and the highest EPS forecast at -$0.40. In 2028, AIDX's EPS is forecast to hit -$0.44 (min: -$0.42, max: -$0.45).

What is AIDX's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: AIDX) forecast ROE is -345.59%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.